Mometason-Mepha
Mometason-Mepha is a generic from Mepha Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 16.05 to CHF 33.75 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Mepha Pharma AG
- ATC code
- R01AD09
- IT group
- 12.02.30 Nasenmittel mit Corticosteroiden
- Active substances
- Mometasoni-17 furoas
- Preparation type
- Generic
- On the SL since
- 01/05/2014
- Last price change
- 01/02/2026
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Nasenspray 50 mcg | Dosierspr 140 Dos | CHF 6.25 | CHF 16.05 | 01/05/2014 | B | 7680632480017 |
| Nasenspray 50 mcg | 3 Dosierspr 140 Dosen | CHF 15.93 | CHF 33.75 | 01/11/2017 | B | 7680632480024 |
Limitation
No limitation is recorded on the SL for this preparation.
More preparations in this group
FAQ
Is Mometason-Mepha covered by Swiss health insurance?
Yes. Mometason-Mepha is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Mometason-Mepha cost in Switzerland?
The public price is the maximum price set by the FOPH and for Mometason-Mepha ranges from CHF 16.05 to CHF 33.75 per pack. The ex-factory price ranges from CHF 6.25 to CHF 15.93. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages